Author: Lexeo Therapeutics

Posted Date:

March 30, 2026

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Lexeo Therapeutics

March 30, 2026
Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference

Lexeo Therapeutics

March 3, 2026
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February

Lexeo Therapeutics

February 8, 2026
Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics

Lexeo Therapeutics

January 28, 2026